The Portfolio Committee on Health has wrapped up its virtual public hearings on the Tobacco Products and Electronic Delivery System Control Bill.

These hearings, which took place over several sessions since March 19, 2025, provided a vital platform for individuals and organisations to articulate their positions on the legislative proposal.

The hearings attracted a diverse group of approximately 59 stakeholders, which included representatives from the tobacco industry, hospitality sector, professional associations, civil society organisations, academic researchers, private enterprises, lobby groups, and public health entities.

Out of those, 48 delivered oral presentations based on their written submissions, while 11 organisations opted out, asserting that their views were sufficiently represented by their peers.

Arguments

Throughout the hearings, a spectrum of opinions emerged, reflecting the complexity of tobacco control in contemporary society. Supporters of the bill celebrated it as a crucial step toward reducing smoking prevalence and safeguarding the health of non-smokers, workers, and minors.

They argued that the legislation effectively addresses regulatory gaps and prioritises public health over the interests of the tobacco industry.

Proposals such as plain packaging for tobacco products were highlighted as instrumental in discouraging consumption, particularly among younger demographics, and in minimising tobacco marketing exposure.

Conversely, critics raised concerns about the bill’s approach to electronic delivery systems, equating them to traditional combustible tobacco products despite their potential as low-risk alternatives that can aid in smoking cessation.

Concerns

Some worried that strategies like plain packaging and display restrictions could inadvertently fuel the growth of counterfeiting and the illicit market, especially given the current enforcement difficulties faced within the country.

Committee Chairperson Dr Sibongiseni Dhlomo underscored the importance of this public participation process, acknowledging the diverse perspectives shared by stakeholders across various sectors.

“The committee received a lot of diverse views on the matter,” he stated, emphasising that the primary aim of the bill is harm reduction, rather than an outright ban on smoking.

This legislative initiative first entered Parliament in 2022 and was deliberated by the committee as part of its efforts during the 7th administration to revisit and refine prior frameworks.

In the lead-up to these hearings, the committee initiated extensive engagement activities, including public submissions and provincial hearings across the country, reaching over 7,900 attendees and garnering 1,113 oral submissions from the public.

Notably, opinions remained closely divided: approximately 44.9% supported the bill, while 44.5% opposed it, with a small fraction registering partial support or withholding their stance.

As the legislative journey progresses, the next phase will see the committee inviting the Department of Health to address the myriad concerns raised.

Following this, a motion of desirability will be adopted to determine whether to advance the bill or halt proceedings, reporting back to the House.

IOL

Source link